Phase I study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and/or recurrent head and neck cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples